Upcoming Q3 2024 Earnings Conference Call
Lantheus Holdings, Inc. (NASDAQ: LNTH), a leader in the radiopharmaceutical sector, is preparing to host an important conference call and webcast to discuss its financial and operational performance for the third quarter of 2024. This event is scheduled for 8:00 a.m. Eastern Time on November 6, 2024, and aims to provide stakeholders with valuable insights into the company's progress and financial results.
Details of the Conference Call
To facilitate access to the call, interested parties are encouraged to register online in advance. Registration is accessible through their investor relations page. It’s recommended that participants register at least fifteen minutes prior to the commencement of the event to ensure a smooth experience and to sidestep any potential delays.
Logistics of the Webcast
After the live session, a replay of the call will be made available approximately two hours post-event, allowing those who were unable to attend the opportunity to listen to the discussion at their convenience. This replay will remain accessible on the investor relations webpage for no less than thirty days, ensuring ample opportunity for stakeholders to catch up on significant developments.
About Lantheus Holdings
Founded over six decades ago, Lantheus has established itself as a prominent force within the field of radiopharmaceuticals. The company is dedicated to enhancing healthcare outcomes through innovative approaches in disease detection and management. With headquarters in Massachusetts and additional offices located in Canada and Sweden, Lantheus continues to deliver groundbreaking medical solutions that allow clinicians to effectively identify, treat, and monitor various diseases.
Commitment to Innovation
Lantheus's commitment lies in crafting advanced solutions that improve patient care. They aim to empower healthcare providers and improve patient outcomes through reliable, cutting-edge technology tailored to meet the evolving healthcare landscape.
Contact Information for Inquiries
For further inquiries regarding the upcoming conference call or investor relations, stakeholders can reach out to:
Mark Kinarney
Vice President, Investor Relations
Phone: 978-671-8842
Email: ir@lantheus.com
Melissa Downs
Senior Director, External Communications
Phone: 646-975-2533
Email: media@lantheus.com
Frequently Asked Questions
When will Lantheus hold their Q3 2024 earnings call?
Lantheus will hold their Q3 2024 earnings call on November 6, 2024, at 8:00 a.m. Eastern Time.
How can I participate in the Lantheus earnings call?
Participants can register for the earning call online through the investor relations section of the Lantheus website.
Will there be a replay of the conference call?
Yes, a replay will be available approximately two hours after the live event and can be accessed on the same web page for at least 30 days.
What is the focus of Lantheus during the call?
The conference call will focus on discussing the financial and operational results of the company for the third quarter, along with updates regarding its business strategy.
How long has Lantheus been in business?
Lantheus has been providing radiopharmaceutical solutions for over 65 years, emphasizing their long-standing commitment to improving healthcare outcomes.
